ReviewAnnals of translational medicine2015

The latest therapeutic strategies after resistance to first generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) in patients with non-small cell lung cancer (NSCLC).

Meng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.